CENTER OF MOLECULAR IMMUNOLOGY
Trials shown by sponsor
Public title | Date of Registration | State |
---|---|---|
CIMAvax-EGF®-post-COVID19 convalescent with respiratory disorders-adults-Phase II (CORVAXCIM) | 18/06/2021 | Registered outdated |
Preventive use of CIMAvax-EGF in patients at high risk of lung cancer. PREVAX | 21/05/2021 | Registered outdated |
Safety and efficacy of CIMAvax®-EGF in combination with tyrosine kinase inhibitors in patients with advanced stage Non-Small Cell Lung Cancer and EGFR mutations | 22/05/2021 | Registered outdated |
CIMAvax-EGF in different maintenance schemes | 12/05/2021 | Registered outdated |
ior®EPOCIM in post-COVID-19 convalescent patients with cardiovascular, renal and/or respiratory disorders | 18/06/2021 | Registered outdated |
Post EUA study of Itolizumab in COVID-19 | 21/03/2022 | Registered outdated |